ORIFARM GENERICS HOLDING A/S: Financial statements 2016
CVR: 27347223
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
ORIFARM GENERICS HOLDING A/S (CVR 27347223) has filed annual accounts for 2016. In 2016, the company reported a gross profit of EUR 1,010,000 and a net result of EUR 9,035,000 compared with DKK 5,160,000 the year before. That is a decrease of 82.1% compared with the year before. Equity in the 2016 report amounted to EUR 34,954,000. The solvency ratio was 52.9%. The company had 165 employees in the financial year.
- Gross Profit
- EUR 1,010,000
- Profit/Loss
- EUR 9,035,000
- Equity
- EUR 34,954,000
- Total Assets
- EUR 66,098,000
- Employees
- 165
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 1M EUR | 9M EUR | 35M EUR | 165 |
| 2015 | - | 5.7M | 5.2M | 194.3M | - |
| 2014 | - | 8.2M | 4.1M | 15.3M | - |
| 2013 | - | 6.8M | -150K | 11.5M | - |
| 2012 | - | 13.1M | 7.1M | 12M | - |
Official annual report
Find more companies like ORIFARM GENERICS HOLDING A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2016
As of July 4, 2016, Birgitte Bøgh-Sørensen has joined the board of directors of ORIFARM GENERICS HOLDING A/S.
As of July 4, 2016, Peter Arend William Burema has left the board of directors of ORIFARM GENERICS HOLDING A/S.
As of July 4, 2016, Claudio Albrecht has left the board of directors of ORIFARM GENERICS HOLDING A/S.
ORIFARM GENERICS HOLDING A/S has published its annual report for 2015. Gross profit came to DKK 5,654,000, and the net result was DKK 5,160,000.
As of May 31, 2016, Claus Christian Bayer has left the board of directors of ORIFARM GENERICS HOLDING A/S.
As of May 31, 2016, Rolf Eckersberg has left the board of directors of ORIFARM GENERICS HOLDING A/S.
About ORIFARM GENERICS HOLDING A/S
ORIFARM GENERICS HOLDING A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2003. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named COPYFARM HOLDING A/S. The management consists of Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Birgitte Bøgh-Sørensen, Mads Fink Eriksen and Nicki Lund Kristensen. The company is owned by ORIFARM GROUP A/S. The company has 0 employees (2016). In 2025, the company reported revenue of DKK 459,463,000 and a net result of DKK 273,125,000 compared with DKK 89,363,000 the year before. Equity in the 2025 report amounted to DKK 2,399,752,000.
